thrombosis

You have access
Anticoagulant Therapy Overview
George A. Fritsma

American Society for Clinical Laboratory Science January 2013, 26 (1) 39-42; DOI: https://doi.org/10.29074/ascls.26.1.39
You have access
Monitoring the Anti-Xa Anticoagulants, from Heparin to Eliquis
George A. Fritsma

American Society for Clinical Laboratory Science January 2013, 26 (1) 48-53; DOI: https://doi.org/10.29074/ascls.26.1.48
You have access
Monitoring the Direct Thrombin Inhibitors
George A. Fritsma

American Society for Clinical Laboratory Science January 2013, 26 (1) 54-57; DOI: https://doi.org/10.29074/ascls.26.1.54
You have access
Heparin-Induced Thrombocytopenia (HIT): A Case Study
Catherine E. Newkirk

American Society for Clinical Laboratory Science January 2010, 23 (1) 5-11; DOI: https://doi.org/10.29074/ascls.23.1.5
You have access
Factor V Leiden: An Overview
Donna M Shaw

American Society for Clinical Laboratory Science October 2006, 19 (4) 218-221; DOI: https://doi.org/10.29074/ascls.19.4.218
You have access
Molecular Diagnostics of Inherited Thrombosis
Stacy C League and W Craig Hooper

American Society for Clinical Laboratory Science October 2005, 18 (4) 271-279; DOI: https://doi.org/10.29074/ascls.18.4.271
You have access
Factor V Leiden with Deep Venous Thrombosis
Jeff Gardner

American Society for Clinical Laboratory Science January 2003, 16 (1) 6-9; DOI: https://doi.org/10.29074/ascls.16.1.6
You have access
Hereditary Deficiencies of Antithrombin III, Protein S, and the Protein C Pathway in Jordanian Thrombosis Patients
Suhair S Eid

American Society for Clinical Laboratory Science October 2002, 15 (4) 196-199; DOI: https://doi.org/10.29074/ascls.15.4.196

Main menu

User menu

Search

thrombosis